Mary Beth Beasley
Overview
Explore the profile of Mary Beth Beasley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
9961
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thunnissen E, Blaauwgeers H, Filipello F, Lissenberg-Witte B, Minami Y, Noguchi M, et al.
Lung Cancer
. 2025 Jan;
199:108060.
PMID: 39793325
Objectives: Evaluating invasion in non-mucinous adenocarcinoma (NMA) of the lung is crucial for accurate pT-staging. This study compares the World Health Organization (WHO) with a recently modified NMA classification. Materials...
2.
Chou T, Dacic S, Wistuba I, Beasley M, Berezowska S, Chang Y, et al.
J Thorac Oncol
. 2024 Nov;
20(3):311-330.
PMID: 39579981
Introduction: With the implementation of low-dose computed tomography screening, multiple pulmonary tumor nodules are diagnosed with increasing frequency and the selection of surgical treatments versus systemic therapies has become challenging...
3.
Beasley M
Surg Pathol Clin
. 2024 May;
17(2):215-225.
PMID: 38692806
Interstitial lung abnormalities (ILA) is a radiographic term, which has recently undergone clarification of definition with creation of 3 subtypes. ILA is defined as incidental identification of computed tomography abnormalities...
4.
Beasley M
Adv Anat Pathol
. 2024 Apr;
31(5):333-343.
PMID: 38666761
Immunohistochemical (IHC) staining represents a comparatively inexpensive testing method that is attractive as a potential alternative to molecular sequencing methods or fluorescence in situ hybridization for pulmonary biomarker testing. While...
5.
Sholl L, Awad M, Roy U, Beasley M, Cartun R, Hwang D, et al.
Arch Pathol Lab Med
. 2024 Apr;
148(7):757-774.
PMID: 38625026
Context.—: Rapid advancements in the understanding and manipulation of tumor-immune interactions have led to the approval of immune therapies for patients with non-small cell lung cancer. Certain immune checkpoint inhibitor...
6.
Husain A, Chapel D, Attanoos R, Beasley M, Brcic L, Butnor K, et al.
Arch Pathol Lab Med
. 2024 Apr;
148(11):1251-1271.
PMID: 38586983
Context.—: Mesothelioma is an uncommon tumor that can be difficult to diagnose. Objective.—: To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data Sources.—: Pathologists involved in the...
7.
Hariri L, Beasley M, Sholl L, Wikenheiser-Brokamp K
Radiology
. 2024 Mar;
310(3):e240414.
PMID: 38530190
No abstract available.
8.
Beasley M
NEJM Evid
. 2024 Feb;
1(6):EVIDe2200096.
PMID: 38319280
Chronic Airway Disease and Vaping - A First StepThe 2019 outbreak of acute lung disease associated with vaping led to the characterization of electronic cigarette (e-cigarette) or vaping-associated lung injury...
9.
Dacic S, Cao X, Bota-Rabassedas N, Sanchez-Espiridion B, Berezowska S, Han Y, et al.
J Thorac Oncol
. 2023 Sep;
19(2):273-284.
PMID: 37717856
Introduction: Morphologic and molecular data for staging of multifocal lung squamous cell carcinomas (LSCCs) are limited. In this study, whole exome sequencing (WES) was used as the gold standard to...
10.
Smith M, Mino-Kenudson M, Butterfield R, Dacic S, Colby T, Churg A, et al.
Arch Pathol Lab Med
. 2023 May;
148(2):168-177.
PMID: 37226833
Context.—: The pathologic diagnosis of usual interstitial pneumonia (UIP) remains a challenging area, and application of histologic UIP guidelines has proved difficult. Objective.—: To understand current practice approaches by pulmonary...